India In-vitro Fertilization Market to Grow with a CAGR of 7.80% through 2030
Growing success rate of IVF
technology and increasing cases of infertility is expected to drive the India
In-vitro Fertilization Market growth in the forecast period, 2026-2030.
According to TechSci Research report, “India
In-vitro Fertilization Market - By Region, Competition, Forecast & Opportunities, 2020-2030”, India In-vitro
Fertilization Market was valued at USD 961.21 Million in 2024 and is expected
to reach USD 1491.85 million by 2030, growing at a CAGR of 7.80% during the
forecast period. The in-vitro fertilization (IVF)
market in India is witnessing strong growth, driven by several key factors.
Rising infertility rates, largely due to lifestyle changes such as delayed
parenthood and increased stress, are boosting demand. Technological advancements
like time-lapse imaging and preimplantation genetic diagnosis are enhancing
success rates. The supportive government initiatives promoting medical tourism,
along with the cost-effectiveness of IVF treatments in India, are drawing
international patients. Growing disposable incomes and greater awareness about
IVF among the public further fuel market expansion.
The Indian In-vitro Fertilization (IVF) market has seen unprecedented growth in recent years, fueled by the increasing prevalence of infertility, technological advancements, and rising awareness and acceptance of IVF treatments. Infertility, defined as the inability to conceive after one year of trying, affects about 10–14% of India’s population, driving demand for effective solutions like IVF. Technological innovations, such as time-lapse imaging and preimplantation genetic testing, have significantly enhanced IVF success rates, making it a popular option for childless couples. Time-lapse imaging enables continuous embryo monitoring without removal from the incubator, minimizing disturbances and boosting implantation chances. Preimplantation genetic testing identifies genetic defects in embryos, ensuring only healthy ones are implanted, lowering the risk of disorders and improving overall success.
These advancements are particularly crucial in a society where childbearing is highly valued. Social stigma around infertility makes successful IVF treatments even more desirable for many couples. Increased public awareness and acceptance have further fueled market growth. Awareness campaigns have educated people about infertility and treatment options, while celebrity endorsements and personal stories have helped destigmatize IVF, making it more mainstream. Despite this growth, high treatment costs and limited insurance coverage remain major barriers for many. However, the Indian IVF market holds strong potential. Continued technological progress will enhance success rates, and expanding awareness will further support growth. However, making IVF more accessible and affordable remains a key challenge to fully realizing the market’s promise.
Browse over XX market data Figures
spread through XX Pages and an in-depth TOC on "India In-vitro Fertilization
Market”
The India In-vitro Fertilization Market is segmented
into technique, product, donor, infertility, embryo, end user, regional
distribution, and company.
Based on technique, the Intracytoplasmic Sperm
Injection (ICSI) IVF technique is projected to dominate the IVF market in
India, owing to its higher success rate compared to Non-ICSI/Traditional IVF.
This is particularly beneficial in cases of severe male infertility, where the
precise and targeted approach of ICSI significantly enhances the chances of
successful fertilization.
Moreover, the growing awareness about the benefits of
ICSI IVF among patients and healthcare providers alike has led to an increased
demand for this advanced technique. The remarkable success stories of couples
who have achieved parenthood through ICSI IVF have further fueled the interest
in this cutting-edge reproductive technology. With the increasing availability
of ICSI IVF in modern healthcare facilities across India, more couples
struggling with infertility are now able to access and benefit from this
revolutionary treatment. Given these factors, it is anticipated that the
dominance of ICSI IVF in the Indian market will continue to expand. As more
individuals and healthcare professionals recognize the potential advantages it
offers in the treatment of infertility, the prevalence of ICSI IVF is poised to
grow, bringing hope and joy to countless families across the nation.
Based on Infertility, female infertility is generally
considered the more dominant factor contributing to the demand for assisted
reproductive treatments. This is partly due to biological complexities,
including ovulation disorders, endometriosis, and age-related decline in fertility,
which are more frequently diagnosed in women undergoing fertility evaluations.
Cultural and societal norms in India also lead to a greater focus on women when
a couple faces difficulty conceiving, resulting in more women undergoing
testing and treatment. Although male infertility is a significant contributor
and often underdiagnosed, the attention tends to remain skewed toward female
factors. As a result, women are more likely to seek IVF and related therapies,
making female infertility a major driver in the market. The emphasis on
motherhood in Indian society further reinforces this trend, with many women
willing to explore advanced reproductive options to fulfill societal
expectations and personal aspirations of becoming a parent.
Based on region, North India is the fastest-growing
segment in the Indian IVF market due to rising awareness about fertility
treatments, increasing infertility rates, and improving healthcare
infrastructure. Urbanization and lifestyle changes in cities like Delhi, Chandigarh,
and Jaipur have led to a higher demand for assisted reproductive technologies. More
IVF clinics are expanding into tier 2 and tier 3 cities, making treatments
accessible to a broader population. Government initiatives, growing acceptance
of IVF, and increasing disposable incomes are further driving demand. The
region's rapid modernization and investment in advanced medical facilities are
accelerating its growth in the IVF sector.
Major companies operating in India
In-vitro Fertilization Market are:
- CK Birla Healthcare Pvt. Ltd.
- Nova IVF
- Indira IVF Hospital Private
Limited.
- Apollo Fertility (Apollo Specialty
Hospitals Pvt. Ltd.)
- Max Healthcare
- MANIPAL HEALTH ENTERPRISES PVT LTD
- Bloom Fertility Centre
- BACC Healthcare Private Limited
- Cloudnine Hospitals
- Morpheus IVF
- Babies and Us Fertility and IVF
Centre (Ind) Pvt Ltd
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The future of the In-vitro Fertilization (IVF) market
in India appears promising, driven by an increasing prevalence of infertility,
advancements in technology, and a growing acceptance of IVF procedures. Trends
suggest a progressive rise in the use of assisted reproductive technology due
to a change in socio-cultural attitudes. However, factors such as expensive
treatment procedures and lack of stringent regulatory framework may pose
challenges to the growth of the market. Nonetheless, the rising middle-class
population and their increasing disposable income are expected to provide ample
opportunities for the expansion of the IVF market in India”, said Mr. Karan
Chechi, Research Director of TechSci Research, a research-based management
consulting firm.
“India In-vitro Fertilization Market By Technique
(ICSI IVF, Non-ICSI/ Traditional IVF), By Product (IVF Culture Media, ICSI
Machine, IVF Incubators, Cryosystem, Others), By Donor (Fresh Non-donor, Frozen
Non-donor, Fresh Donor, Frozen Donor), By Infertility (Male, Female), By Embryo
(Fresh Embryo, Frozen-thawed Embryo), By End User (Fertility Clinics,
Hospitals, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F”,
has evaluated the future growth potential of India In-vitro Fertilization
Market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in India In-vitro
Fertilization Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com